PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
6 hedge funds and large institutions have $1.88M invested in PureTech Health in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
1.05% less ownership
Funds ownership: 1.47% → 0.42% (-1.1%)
19% less capital invested
Capital invested by funds: $2.33M → $1.88M (-$451K)
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$439K |
| 2 |
SS
SBI Securities
Tokyo,
Japan
|
+$35 |
Top Sellers
PRTC Hedge Fund Activity: Q3 2025 in Review
6 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q3 2025, worth a combined $1.88M — down 19% from $2.33M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PRTC and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Pentwater Capital Management, adding an estimated $439K. The largest seller was Portolan Capital Management, exiting entirely with an estimated $479K sold.
- 6 institutional investors held PureTech Health (PRTC) as of Q3 2025, down from 8 in Q2 2025.
- Funds reported $1.88M of PureTech Health stock for Q3 2025, down 19% quarter-over-quarter.
- 1 fund opened new PureTech Health positions in Q3 2025 and 3 closed out, a net change of -2 holders.
- The largest PureTech Health buyer in Q3 2025 was Pentwater Capital Management, an estimated $439K added.
- The largest PureTech Health seller in Q3 2025 was Portolan Capital Management, an estimated $479K sold.
Based on aggregated 13F filings for Q3 2025.